Business Context and Reporting Period
Company: Blue Owl Technology Finance Corp. (OTF)
Filing Type: Form 8-K (Current Report)
Date of Report: October 30, 2025
Event: Entry into a Material Definitive Agreement and Creation of a Direct Financial Obligation.
On October 30, 2025, the Company's wholly owned subsidiary, Athena Funding II LLC, entered into an Omnibus Amendment No. 2 to its credit facility. This amendment replaced the original Loan and Management Agreement with an Amended and Restated Credit Agreement and an Amended and Restated Purchase and Sale Agreement.
Key Financial Metrics and Debt Structure
This filing details a restructuring of the Company's secured credit facility rather than reporting operational financial results (revenue, profit, or cash flow). Key debt metrics include:
- Commitment Increase: The credit facility commitment was increased from $300,000,000 to $500,000,000.
- Interest Rate Adjustment:
- Reinvestment Period: Reduced from Cost of Funds + 2.625% (or Term SOFR + 2.625%) to Term SOFR + 2.00%.
- Post-Reinvestment Period: Reduced from 3.025% to 2.35% (over Term SOFR).
- Lenders: MUFG Bank, Ltd. (Administrative Agent) and State Street Bank and Trust Company (Collateral Agent).
Material Changes Versus Prior Period
The filing outlines significant modifications to the Company's debt instrument compared to the original agreement dated November 8, 2022:
- Reinvestment Period Extension: Extended from October 27, 2026, to October 30, 2028.
- Maturity Date Extension: Extended from October 27, 2029, to October 30, 2030.
- Cost of Borrowing: The applicable margin was reduced across both the Reinvestment Period and the post-Reinvestment Period.
- Capacity: Total available commitment increased by $200,000,000.
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain explicit forward-looking guidance, earnings outlook, or management commentary beyond the description of the transaction terms. The primary strategic implication is the extension of the investment horizon and the reduction of borrowing costs.
Risks and Contingencies: The filing notes that the summary of provisions is qualified in its entirety by reference to the full agreements filed as Exhibit 10.1. No specific new risks or contingencies were disclosed in the text of this 8-K.
Investor Verification Checklist
- Verify the full terms of the Omnibus Amendment No. 2 and Amended and Restated Purchase and Sale Agreement in Exhibit 10.1 and 10.3.
- Confirm the impact of the Term SOFR benchmark on future interest expense compared to the previous cost of funds rate.
- Assess the utilization of the increased $500 million commitment and whether additional capital has been drawn.
- Review the Reinvestment Period mechanics to understand the timeline for asset deployment versus the new 2028 deadline.